ALMS
Alumis Inc
NASDAQ: ALMS · HEALTHCARE · BIOTECHNOLOGY
$24.69
+7.86% today
Updated 2026-04-30
Market cap
$3.17B
P/E ratio
—
P/S ratio
131.85x
EPS (TTM)
$-2.86
Dividend yield
—
52W range
$3 – $31
Volume
1.5M
Alumis Inc (ALMS) Earnings
Quarterly earnings history, analyst estimates, and stock price reaction.
EPS beat streak
4 of 8
Last 8 quarters
Avg EPS surprise
+48.9%
Last 4 quarters
Revenue YoY growth
-36.5%
Most recent quarter
EPS YoY growth
+85.5%
Most recent quarter
Earnings surprise history (last 12 quarters)
Beat estimate Missed estimate
Quarterly EPS and revenue trend
Quarterly revenue EPS (diluted)
How the stock reacts to earnings
Avg 1-day reaction
+9.7%
Last 2 reports
Positive reaction rate
100%
2 of 2 quarters
Largest single-day move
+14.1%
2026-03-25
| Report date | EPS actual | Surprise | Close before | Close after | 1-day reaction |
|---|---|---|---|---|---|
| 2026-03-25 | $-0.25 | +74.2% | $23.07 | $26.32 | +14.1% |
| 2025-11-13 | $-1.06 | -6.0% | $5.24 | $5.52 | +5.3% |
Quarterly earnings history
| Fiscal quarter ending | EPS estimate | EPS actual | Surprise | Revenue | YoY revenue |
|---|---|---|---|---|---|
| 2025-12-31 | $-0.98 | $-0.25 | +74.2% | $1.93M | -36.5% |
| 2025-09-30 | $-1.00 | $-1.06 | -6.0% | $2.07M | — |
| 2025-06-30 | $-1.39 | $0.77 | +155.5% | $2.67M | — |
| 2025-03-31 | $-1.42 | $-1.82 | -27.9% | $17.39M | — |
| 2024-12-31 | $-1.32 | $-1.74 | -31.8% | $3.04M | — |
| 2024-09-30 | $-1.81 | $-1.73 | +4.2% | — | — |
| 2024-06-30 | $-1.67 | $-1.04 | +37.8% | — | — |
| 2024-03-31 | $0.00 | $-4.50 | — | — | — |
Frequently asked questions
Has Alumis Inc beaten earnings estimates?
Alumis Inc has beaten Wall Street EPS estimates in 4 of its last 8 quarterly reports, with an average EPS surprise of +48.9% over the last 4 quarters.
How does ALMS stock react to earnings?
ALMS stock has moved an average of +9.7% in the trading day following earnings over its last 2 reports, with positive reactions in 100% of those quarters.
What is Alumis Inc's revenue growth rate?
Alumis Inc reported year-over-year revenue growth of -36.5% in its most recent quarter, with EPS growing +85.5% year-over-year.